Potassium channel modulators
AssigneeJohn Wyeth & Brother Limited
InventorsRoger Crossley, Albert Opalko, David Geraint Owen, Brian Robertson
Life of this patent
Estimating the term…
Loading patent…
AssigneeJohn Wyeth & Brother Limited
InventorsRoger Crossley, Albert Opalko, David Geraint Owen, Brian Robertson
Estimating the term…
This invention concerns peptides (I) having intracellular potassium channel modulating activity comprising the amino acid sequence shown in SEQ ID No: 2: (N terminal function) (I) Met Ile Ser Ser Val Cys Val Ser Ser 1 5} Tyr Arg Gly Arg Lys Ser Gly Asn Lys 10 15 Pro Pro Ser Lys Thr Cys Leu Lys Glu Glu 20 25 (C terminal function) in which the cysteines are optionally linked via a disulphide bridge and wherein ______________________________________ Met represents L-methionine Ile represents L-isoleucine Ser represents L-serine Val represents L-valine Cys represents L-cysteine Tyr represents L-tyrosine Arg represents L-arginine Gly represents glycine Lys represents L-lysine Asn represents L-asparagine Pro represents L-proline Thr represents L-threonine Leu represents L-leucine Glu represents L-glutamic acid ______________________________________ or a variant thereof, with the proviso that excluded is the 13-Lys variant (where 13-Arg is replaced by 13-Lys) in which the cysteines are not linked via a disulphide bridge, which are useful in a test method of screening for compounds having potassium channel modulating activity.
A peptide (I) having intracellular potassium channel modulating activity and having a 28 amino acid sequence, as listed in SEQ ID No:
Dependencies are inferred from the claim text.